Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis

Abstract

Our results demonstrate that direct injection of autologous expanded MSCs into the spinal cord of ALS patients is safe, with no significant acute or late toxicity, and well tolerated. The clinical results seem to be encouraging.